RAP 0.00% 20.5¢ resapp health limited

So not "no revenue at all" as you stated???? and from the last...

  1. 26,627 Posts.
    lightbulb Created with Sketch. 1727
    So not "no revenue at all" as you stated???? and from the last quarterly "Research and development payments increased to $1,625,000 (Q3: $410,000) due to the additional costs for recruitment in US and India COVID-19 studies during the quarter. Advertising and marketing costs decreased to $55,000 (Q3: $70,000). Staff costs remained approximately constant at $1,050,000 (Q3: $1,018,000). Administration and corporate costs increased to $766,000 (Q3: $257,000) due to costs associated with recent corporate and transactional activity"
    Last edited by AlCp: 17/08/22
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.